Meeting rejects Biotechnology Bill
News | 29 July 2010
... has demanded withdrawal of the proposed Biotechnology Regulatory Authority Bill and other legislations that facilitate easy entry of genetic engineering ...
Click on the link to read the full article at The Hindu
(This link will open in a new window)
- GlaxoSmithKline’s Avandia still available in UK, despite MHRA call for its suspension
- Israel relaxes restrictions on medical marijuana; scientists develop new HIV/AIDS treatment
- Tough road ahead for some generics after USA’s Federal Circuit Patent Use Code decisions
- Bausch & Lomb moves to acquire Miochol-E from Novartis as required by US competition authority
- German drug price curbs will hamper orphan drug development, says BIO Deutschland
